GGrantIndex
← Search

CANCER CENTER CORE GRANT

$2,788,272P30FY2000CANIH

University Of Colorado Denver, Aurora CO

Investigators

Linked publications, trials & patents

Paper 39763739Paper 39737640Paper 39726772Paper 39711559Paper 39711135Paper 39684443Paper 39677775Paper 39677720Paper 39677022Paper 39671500Paper 39671496Paper 39630148Paper 39609428Paper 39604567Paper 39603869Paper 39574899Paper 39564580Paper 39554114Paper 39436696Paper 39400608Paper 39384405Paper 39342284Paper 39321266Paper 39311710Paper 39282307Paper 39266537Paper 39264810Paper 39215796Paper 39201277Paper 39191549Paper 39147413Paper 39139560Paper 39136655Paper 39120971Paper 39091762Trial NCT05073848Trial NCT05053737Trial NCT05006040Trial NCT04993859Trial NCT04988490Trial NCT04973007Trial NCT04963283Trial NCT04940468Trial NCT04925193Trial NCT04922112Trial NCT04916990Trial NCT04882111Trial NCT04866758Trial NCT04863092Trial NCT04634110Trial NCT04611022Trial NCT04565457Trial NCT04558138Trial NCT04544592Trial NCT04541407Trial NCT04535102Trial NCT04520867Trial NCT04486573Trial NCT04471363Trial NCT04408092Trial NCT04305366Trial NCT04300478Trial NCT04294693Trial NCT04208243Trial NCT04092803Trial NCT04091867Trial NCT04066218Trial NCT04042935Trial NCT04035408Trial NCT04028167Trial NCT04028063Trial NCT04001101Trial NCT03995082Trial NCT03976193Trial NCT03970226Trial NCT03958565Trial NCT03900793Trial NCT03891654Trial NCT03881098Trial NCT03781154Trial NCT03734653Trial NCT03617679Trial NCT03325634Trial NCT01886859Trial NCT01426334Trial NCT01232829Trial NCT00778167Patent 9434994Patent 8734778Patent 8715649Patent 8343502Patent 8337830Patent 8221763Patent 8153136Patent 8067559Patent 7910315Patent 7595060Patent 7563447Patent 7465454Patent 7083787

Abstract

This application requests funding for a CCSG grant for the University of Colorado Cancer Center (UCCC) for years 09-13. The University of Colorado Cancer Center is a "Center" within the School of medicine at the University of Colorado Health Sciences Center. The Cancer Center goals are; 1) to contribute through coordinated research, clinical, prevention and control and educational activities effort to the eventual elimination of cancer as a human health problem, and 2) to provide the citizens of the State of Colorado and the Rocky Mountains region with state of the art cancer research, therapy, prevention, control and educational programs. The Cancer Center serves more than 6 million people in Colorado and the 7 surrounding states in the Rocky Mountain region. The over 280 Cancer Center members have more than $48 million (annual direct costs) in peer- reviewed grants an contracts relating to the cancer problem. Cancer Center members provide care to 15-20% of the cancer population in the region and enter more than 1,600 patients on cancer clinical trials each year. The Cancer Center enters an increasing number of patients of clinical trials emphasizing novel trials of the Center and high priority trials of the National Cancer Institute. The majority of cancer educational, prevention and control programs in the region are organized by Cancer Center members. The Center provides the major centralized support for these functions through its 11 shared "core" facilities in Biostatistics, Clinical Investigations, Cytogenetics, Fermentation, Flow Cytometry, Histopathology/Tissue Procurement, Laboratory Animals/Transgenic Animals, Macromolecular Resources, Radiological Sciences, Immunology and Tissue Culture/Monoclonal Antibodies. The Cancer Center has 14 institutional members including the Health Sciences Center schools, affiliated hospitals and other institutions with a primary focus in cancer. The chief executive officers of these organizations form the Cancer Center Board which assures coordination of the cancer effort in the region. The Cancer Center has four major program divisions: Basic Research, Clinical Activities, Education and prevention and Control and is developing a Community Research Division. The Basic Research Division is divided into: Immunology; Molecular Biology; Growth Regulation; Cell Surface; Hormones an Cancer; Chromosomes and Mutation. The Clinical Division is divided into: Adult Clinical Oncology, Breast Cancer, Lung Cancer and Pediatric oncology; and the Prevention and Control Division is divided into Causation and Clinical Prevention and Control programs. The UCCC is currently an NCI designated "Clinical Cancer Center". Our plans are to seek approval as an "NCI Comprehensive Cancer Center" during the next funding cycle.

View original record on NIH RePORTER →